5-alpha reductase inhibitors reduce prostate cancer risk, but not all experts are ready to support their chemopreventive role

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2010年 / 45卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [31] Differential expression and quantitation of 5-alpha reductase (5αR) in prostate cancer
    Chikkamuniyappa, S
    McMasters, R
    Ghosh, P
    Thompson, I
    Leach, R
    Troyer, D
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 133A - 133A
  • [32] 5-alpha Reductase Inhibitors and Prostate Cancer Incidence and Mortality among Men with Benign Prostatic Hyperplasia
    Bhaskaran, Krishnan
    Douglas, Ian
    Smeeth, Liam
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 479 - 479
  • [33] The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality
    Wallner, Lauren P.
    DiBello, Julia R.
    Li, Bonnie H.
    Van den Eeden, Stephen K.
    Weinmann, Sheila
    Ritzwoller, Debra P.
    Abell, Jill E.
    D'Agostino, Ralph, Jr.
    Loo, Ronald K.
    Aaronson, David S.
    Horwitz, Ralph, I
    Jacobsen, Steven J.
    [J]. UROLOGY, 2018, 119 : 70 - 78
  • [34] 5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
    Ziting Wang
    Kaiying Wang
    Han Yang Ong
    Woon Chau Tsang
    Qing Hui Wu
    Edmund Chiong
    [J]. BMC Urology, 23
  • [35] 5 alpha-reductase inhibitors in prostate cancer
    Gormley, GJ
    [J]. ENDOCRINE-RELATED CANCER, 1996, 3 (01) : 57 - 63
  • [36] Risk of Gynecomastia with Use of 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
    Hagberg, Katrina Wilcox
    Divan, Hozefa A.
    Nickel, J. Curtis
    Fang, Shona
    Jick, Susan S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 531 - 532
  • [37] 5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
    Wang, Ziting
    Wang, Kaiying
    Ong, Han Yang
    Tsang, Woon Chau
    Wu, Qing Hui
    Chiong, Edmund
    [J]. BMC UROLOGY, 2023, 23 (01)
  • [38] 5-ALPHA REDUCTASE INHIBITORS IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER: IMPACT ON DISEASE PROGRESSION AND CURATIVE INTERVENTION
    Abreu, Andre Luis de Castro
    Gill, Inderbir
    Bahn, Duke
    Shoji, Sunao
    Marien, Arnaud
    Cai, Jie
    Chopra, Sameer
    Azhar, Raed
    Wong, Kelvin
    Metcalfe, Charles
    Satkunasivam, Raj
    Ukimura, Osamu
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E756 - E756
  • [39] THE PROGNOSTIC-SIGNIFICANCE OF 5-ALPHA REDUCTASE IN THE TREATMENT AND MANAGEMENT OF CANCER OF THE PROSTATE
    HABIB, FK
    BUSUTTIL, A
    ROBINSON, RA
    CHISHOLM, GD
    [J]. PROSTATE, 1984, 5 (03): : 334 - 334
  • [40] 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
    Hamilton, Robert J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (07) : 1259 - 1260
12345